Royal, Simon
Keeling, Stuart
Kelsall, Nick
Price, Larry
Fordham, Richard
Xydopoulos, Georgios
Dawson, Gerard R.
Kingslake, Jonathan
Morriss, Richard
Article History
Received: 12 August 2021
Accepted: 28 March 2022
First Online: 29 April 2022
Declarations
:
: The study received national NHS ethics committee approval obtained from the Wales NHS REC 6 (reference number 19/WA/0344) in accordance with the Declaration of Helsinki. All methods were performed in accordance with these relevant guidelines, ethics approval and regulations. Each participant gave written informed consent to the collection of their data and its use in the Alpha-Stim AID CES pathway. The control group used anonymised routinely collected data.
: Not applicable.
: GD and JK are directors and shareholders in P1vital Products Ltd. who manufacture i-spero®. LP, RF and GX received payment from the MicroCurrent Site Ltd., the UK distributor of the Alpha-Stim AID device, or Electromedical Products Inc., the manufacturer of the Alpha-Stim AID device. No other competing interests declared.